Concepedia

Author

Alexandre Abizaid

Instituto Dante Pazzanese de CardiologiaORCID

Also Known As

A A C Abizaid, A Abizaid, A Antonio Cunha Abizaid, A C Abizaid, A. A. Abizaid, A. Abizaid, A.A. Abizaid, A.C Abizaid, A.C. Abizaid, A.S Abizaid

1.2K

Publications

26.6K

Citations

80

H-Index

96

Concepts

All Affiliations

Instituto Dante Pazzanese de CardiologiaCardiovascular Research FoundationUniversidade de São PauloColumbia University Irving Medical CenterHospital do Coração
AA

About

Alexandre Abizaid is an author at Instituto Dante Pazzanese de Cardiologia specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

46

93

6.3K

2

Public Health

18

24

1.6K

3

Engineering

11

12

792

4

Health Sciences

3

3

194

5

Law

1

1

104

Alexandre Abizaid

×

212

Publications

15.2K

Citations

60

H-Index

YearCitations

Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries

J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid,

Circulation

2001

793

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

Philip Urban, Ian T. Meredith, Alexandre Abizaid,

New England Journal of Medicine

2015

790

Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents

J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid,

Circulation

2001

667

Percutaneous Recanalization of Chronically Occluded Coronary Arteries

Gregg W. Stone, David E. Kandzari, Roxana Mehran,

Circulation

2005

519

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

Alexandre Abizaid, Ran Kornowski, Gary S. Mintz,

Journal of the American College of Cardiology

1998

459

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI

Gennaro Giustino, Alaide Chieffo, Tullio Palmerini,

Journal of the American College of Cardiology

2016

424

Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial

Patrick W. Serruys, Muzaffer Değertekin, Kengo Tanabe,

Circulation

2002

354

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

Michael Haude, Hüseyin İnce, Alexandre Abizaid,

The Lancet

2015

347

Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients

Alexandre Abizaid, Marco A. Costa, Marinella Centemero,

Circulation

2001

340

Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death

Ander Regueiro, Axel Linke, Azeem Latib,

JAMA

2016

323

Page 1